SCS — Stem Cells Spin SA Income Statement
0.000.00%
- PLN14.96m
- PLN14.99m
- PLN0.42m
Annual income statement for Stem Cells Spin SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PRESS | ARS | ARS | ARS | ARS |
Standards: | — | PAS | PAS | PAS | PAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.582 | 0.268 | 0.526 | 0.248 | 0.419 |
Cost of Revenue | |||||
Gross Profit | 0.563 | 0.261 | 0.502 | 0.228 | 0.375 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.24 | 0.227 | 0.605 | 0.217 | 0.57 |
Operating Profit | -0.656 | 0.042 | -0.079 | 0.031 | -0.15 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.678 | 0.006 | -0.127 | 0.027 | -0.154 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.678 | 0.006 | -0.127 | 0.027 | -0.154 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.678 | 0.006 | -0.127 | 0.027 | -0.154 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.678 | 0.006 | -0.127 | 0.027 | -0.154 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.016 | 0 | -0.003 | -0.005 | -0.004 |
Dividends per Share |